User login
A meta-analysis of 8 randomized controlled trials that included a total of 183 people with depression or bipolar disorder found that a single dose ketamine, whether IV or intranasal, led to a rapid reduction of depressive symptoms that lasted for up to 7 days. The medication appeared to be more effective for unipolar depression than bipolar depression.
To read the full article, go to Federal Practitioner: http://www.fedprac.com/the-publication/past-issues-single-view/ketamine-rapid-relief-for-depression/25d6023bd77eb9c4788adc4c1cf3ff48/ocregister.html.
A meta-analysis of 8 randomized controlled trials that included a total of 183 people with depression or bipolar disorder found that a single dose ketamine, whether IV or intranasal, led to a rapid reduction of depressive symptoms that lasted for up to 7 days. The medication appeared to be more effective for unipolar depression than bipolar depression.
To read the full article, go to Federal Practitioner: http://www.fedprac.com/the-publication/past-issues-single-view/ketamine-rapid-relief-for-depression/25d6023bd77eb9c4788adc4c1cf3ff48/ocregister.html.
A meta-analysis of 8 randomized controlled trials that included a total of 183 people with depression or bipolar disorder found that a single dose ketamine, whether IV or intranasal, led to a rapid reduction of depressive symptoms that lasted for up to 7 days. The medication appeared to be more effective for unipolar depression than bipolar depression.
To read the full article, go to Federal Practitioner: http://www.fedprac.com/the-publication/past-issues-single-view/ketamine-rapid-relief-for-depression/25d6023bd77eb9c4788adc4c1cf3ff48/ocregister.html.